Kolon Tissuegene Stock Forecast

Sell candidate since Jun 30, 2026 Loss -79.04%

The Kolon Tissuegene, Inc. stock price gained 1.50% on the last trading day (Tuesday, 11th Aug 2026), rising from ₩19,330.00 to ₩19,620.00. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 8.61% from a day low at ₩18,230.00 to a day high of ₩19,800.00. The price has risen in 7 of the last 10 days and is up by 34.75% over the past 2 weeks. Volume fell on the last day by -2 million shares and in total, 2 million shares were bought and sold for approximately ₩41.30 billion. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Due to the high volatility and the trend direction we are not able to give forecast range for this stock. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

950160.KQ Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, July 30, 2026, and so far it has risen 68.12%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Kolon Tissuegene, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at ₩55,754.00. On a fall, the stock will find some support from the short-term average at ₩17,578.57. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal.

Support, Risk & Stop-loss for Kolon Tissuegene, Inc. stock

Kolon Tissuegene, Inc. finds support from accumulated volume at ₩18,660.00 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved ₩1,570.00 between high and low, or 8.61%. For the last week, the stock has had daily average volatility of 17.49%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (950160.KQ) For The Upcoming Trading Day Of Wednesday 12th

For the upcoming trading day on Wednesday, 12th we expect Kolon Tissuegene, Inc. to open at ₩19,216.67, and during the day (based on 14 day Average True Range), to move between ₩16,591.29 and ₩22,648.71, which gives a possible trading interval of +/-₩6,057.42 (+/-36.51%) up or down from last closing price. If Kolon Tissuegene, Inc. takes out the full calculated possible swing range there will be an estimated 36.51% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at ₩18,660.00 (4.89%) than the resistance at ₩21,050.00 (7.29%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Kolon Tissuegene, Inc. stock A Buy?

Kolon Tissuegene, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -3.586 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 12, 2026 - ₩19,216.67 ( 2.06%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk